Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.
作者信息
Ghany Marc G, Morgan Timothy R
机构信息
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
Chief of Hepatology, Veterans Affairs Long Beach Healthcare System, Long Beach, CA.
出版信息
Hepatology. 2020 Feb;71(2):686-721. doi: 10.1002/hep.31060.
Abstract
摘要
相似文献
1
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.《2019年丙型肝炎指南更新：美国肝病研究协会-美国传染病学会关于丙型肝炎病毒感染检测、管理及治疗的建议》
Hepatology. 2020 Feb;71(2):686-721. doi: 10.1002/hep.31060.
2
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.2018 年丙型肝炎治疗指南更新：美国肝病研究学会-美国传染病学会丙型肝炎病毒感染检测、管理和治疗推荐意见。
Clin Infect Dis. 2018 Oct 30;67(10):1477-1492. doi: 10.1093/cid/ciy585.
3
Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.《2023年丙型肝炎指南更新：美国肝病研究学会-美国感染病学会关于丙型肝炎病毒感染检测、管理及治疗的建议》
Clin Infect Dis. 2023 May 25. doi: 10.1093/cid/ciad319.
4
An emerging epidemic. Chronic hepatitis C in children.一种新出现的流行病。儿童慢性丙型肝炎。
Adv Nurse Pract. 1999 Oct;7(10):42-6; quiz 47-8.
5
Evaluating CKD/ESRD patient with hepatitis C infection: How to interpret diagnostic testing and assess liver injury.评估丙型肝炎感染的慢性肾脏病/终末期肾病患者：如何解读诊断检测结果及评估肝损伤
Semin Dial. 2019 Mar;32(2):119-126. doi: 10.1111/sdi.12760. Epub 2019 Jan 1.
6
Society for Maternal-Fetal Medicine Consult Series #56: Hepatitis C in pregnancy-updated guidelines: Replaces Consult Number 43, November 2017.母胎医学会咨询系列第 56 号：妊娠期丙型肝炎——更新指南：取代 2017 年 11 月的咨询第 43 号。
Am J Obstet Gynecol. 2021 Sep;225(3):B8-B18. doi: 10.1016/j.ajog.2021.06.008. Epub 2021 Jun 8.
7
Chronic hepatitis C: early intervention.慢性丙型肝炎：早期干预
Hosp Pract (1995). 1998 Jun 15;33(6):101-5, 108, 111-4. doi: 10.1080/21548331.1998.11443707.
8
Hepatitis C in pregnancy: screening, treatment, and management.妊娠期丙型肝炎：筛查、治疗与管理
Am J Obstet Gynecol. 2017 Nov;217(5):B2-B12. doi: 10.1016/j.ajog.2017.07.039. Epub 2017 Aug 4.
9
Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.丙型肝炎指南：美国肝病研究学会-美国感染病学会关于丙型肝炎病毒感染成人检测、管理及治疗的建议
Hepatology. 2015 Sep;62(3):932-54. doi: 10.1002/hep.27950. Epub 2015 Aug 4.
10
Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations.慢性病毒性肝炎与HIV感染共识会议：西班牙最新建议
J Viral Hepat. 2004 Jan;11(1):2-17. doi: 10.1046/j.1365-2893.2003.00491.x.
引用本文的文献
1
Hepatitis C reinfection in patients with sustained virologic response at a national hospital in Peru, 2024.2024年秘鲁一家国立医院中病毒学持续应答患者的丙型肝炎再感染情况
Rev Peru Med Exp Salud Publica. 2025 Aug 25;42(2):223-224. doi: 10.17843/rpmesp.2025.422.14428.
2
Hepatitis C Virus: Epidemiological Challenges and Global Strategies for Elimination.丙型肝炎病毒：流行病学挑战与全球消除策略
Viruses. 2025 Jul 31;17(8):1069. doi: 10.3390/v17081069.
3
Hepatitis C Treatment Outcomes for Patients With Infective Endocarditis Treated by an Interdisciplinary Team.由跨学科团队治疗的感染性心内膜炎患者的丙型肝炎治疗结果。
Open Forum Infect Dis. 2025 Jul 21;12(8):ofaf431. doi: 10.1093/ofid/ofaf431. eCollection 2025 Aug.
4
A scoping review on HCV screening strategies: population to screen and the test types.关于丙型肝炎病毒（HCV）筛查策略的范围综述：筛查人群及检测类型
BMC Public Health. 2025 Jul 30;25(1):2589. doi: 10.1186/s12889-025-23809-7.
5
The effect of spatial variation on linkage to care and treatment rates among patients with hepatitis C: A Canadian population-based study.空间变异对丙型肝炎患者获得治疗及治疗率的影响：一项基于加拿大人群的研究。
Can Liver J. 2024 Dec 19;7(4):447-457. doi: 10.3138/canlivj-2024-0031. eCollection 2024 Dec.
6
Facilitated Telemedicine as a Patient-Centered, Sociotechnical Intervention to Integrate Hepatitis C Treatment Into Opioid Treatment Programs and Overcome the Digital Divide Among Underserved Populations: Qualitative Study.以患者为中心的辅助远程医疗：一种将丙型肝炎治疗纳入阿片类药物治疗项目并克服弱势群体数字鸿沟的社会技术干预措施：定性研究
JMIR Public Health Surveill. 2025 Jul 16;11:e68854. doi: 10.2196/68854.
7
Hepatitis C-Everything a Primary Care Physician Needs to Know About Diagnosis, Management, and Follow-Up.丙型肝炎——基层医疗医生需要了解的关于诊断、管理及随访的一切。
J Clin Med. 2025 Jul 7;14(13):4801. doi: 10.3390/jcm14134801.
8
Taking the opportunity of COVID testing to screen vulnerable populations for hepatitis B, hepatitis C, syphilis, and human immunodeficiency virus in Central Brazil.利用新冠病毒检测的机会，对巴西中部的弱势群体进行乙型肝炎、丙型肝炎、梅毒和人类免疫缺陷病毒筛查。
PLoS One. 2025 Jul 11;20(7):e0325859. doi: 10.1371/journal.pone.0325859. eCollection 2025.
9
Trends in liver cancer rehabilitation needs, disease burden, and attributable risk factors in China, 1990-2021.1990 - 2021年中国肝癌康复需求、疾病负担及归因风险因素的趋势
Sci Rep. 2025 May 5;15(1):15682. doi: 10.1038/s41598-025-00317-7.
10
Prevalence of opportunistic infections in Syrian inflammatory bowel disease patients on biologic therapy: a multi-center retrospective cross-sectional study.叙利亚接受生物治疗的炎症性肠病患者机会性感染的患病率：一项多中心回顾性横断面研究。
BMC Infect Dis. 2025 May 4;25(1):652. doi: 10.1186/s12879-025-11063-6.
本文引用的文献
1
Glecaprevir/pibrentasvir for 8 weeks in treatment-naïve patients with chronic HCV genotypes 1-6 and compensated cirrhosis: The EXPEDITION-8 trial.格卡瑞韦/哌仑他韦治疗初治慢性 HCV 基因型 1-6 且代偿期肝硬化患者 8 周：EXPEDITION-8 试验。
J Hepatol. 2020 Mar;72(3):441-449. doi: 10.1016/j.jhep.2019.10.020. Epub 2019 Nov 2.
2
A systematic review and meta-analysis of community and primary-care-based hepatitis C testing and treatment services that employ direct acting antiviral drug treatments.采用直接作用抗病毒药物治疗的基于社区和初级保健的丙型肝炎检测和治疗服务的系统评价和荟萃分析。
BMC Health Serv Res. 2019 Oct 28;19(1):765. doi: 10.1186/s12913-019-4635-7.
3
Hepatitis C Virus NAT-Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus-Negative Recipients: A Real-World Experience.丙型肝炎病毒核酸检测阳性的实体器官移植物移植到丙型肝炎病毒阴性受者：真实世界的经验。
Hepatology. 2020 Jul;72(1):32-41. doi: 10.1002/hep.31011. Epub 2020 Apr 15.
4
Ultra-short duration direct acting antiviral prophylaxis to prevent virus transmission from hepatitis C viremic donors to hepatitis C negative kidney transplant recipients.超短疗程直接作用抗病毒预防治疗，以预防丙型肝炎病毒血症供者向丙型肝炎阴性肾移植受者的病毒传播。
Am J Transplant. 2020 Mar;20(3):739-751. doi: 10.1111/ajt.15664. Epub 2019 Nov 15.
5
Real-world experience of 12-week direct-acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection.慢性丙型肝炎病毒感染患者使用 glecaprevir 和 pibrentasvir 12 周直接抗病毒治疗方案的真实世界经验。
J Gastroenterol Hepatol. 2020 May;35(5):855-861. doi: 10.1111/jgh.14874. Epub 2019 Nov 19.
6
Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.丙型肝炎病毒血症供肺者肺移植中病毒传播的预防：一项开放标签、单中心、初步试验。
Lancet Respir Med. 2020 Feb;8(2):192-201. doi: 10.1016/S2213-2600(19)30268-1. Epub 2019 Oct 9.
7
Rapid Regression of B-Cell Non-Hodgkin's Lymphoma after Eradication of Hepatitis C Virus by Direct Antiviral Agents.通过直接抗病毒药物根除丙型肝炎病毒后B细胞非霍奇金淋巴瘤的快速消退
Case Rep Gastroenterol. 2019 Jul 26;13(2):336-341. doi: 10.1159/000501546. eCollection 2019 May-Aug.
8
Evaluation of depression, anxiety and quality of life in hepatitis C patients who treated with direct acting antiviral agents.接受直接抗病毒药物治疗的丙型肝炎患者的抑郁、焦虑及生活质量评估
Turk J Gastroenterol. 2019 Sep;30(9):801-806. doi: 10.5152/tjg.2019.18679.
9
Generic sofosbuvir/ledipasvir for the treatment of genotype 4 chronic hepatitis C in Egyptian children (9-12 years) and adolescents.通用索磷布韦/利迪帕韦治疗埃及儿童（9-12 岁）和青少年基因型 4 慢性丙型肝炎。
Hepatol Int. 2019 Nov;13(6):706-714. doi: 10.1007/s12072-019-09985-w. Epub 2019 Sep 12.
10
National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys.国家趋势与 HCV 病毒血症肾脏移植的 1 年结果。
J Am Soc Nephrol. 2019 Oct;30(10):1939-1951. doi: 10.1681/ASN.2019050462. Epub 2019 Sep 12.
Zotero 插件